25 June 2026
Advocate General Szpunar Makes Questionable Proposal to Relax Language Requirements for Labelling of Parallel-Traded Medicinal Products
10 min read
On 11 June 2026, Advocate General Szpunar delivered his non-binding Opinion concerning the application of labelling and national language requirements under Directive 2001/83/EC “on medicinal products for human use” to parallel-imported medicinal products.
The Opinion is highly questionable and, if followed by the Court of Justice of the European Union, would mark yet another step in the gradual erosion of public health protection in favour of the free movement of parallel-traded goods.
Attached is a note discussing the Opinion.
Attachments:
Key contacts
News & insights
2 min
read
read
News
Territorial Supply Constraints – Mid-sized Competition Authorities Favour New Legislative Instrument
14 August 2026
1 min
read
read
News
VBB competition team recognised in Lexology Index: Competition 2026
11 August 2026
2 min
read
read
News
Belgium’s Interfederal Screening Committee Issues First-Ever Prohibition of Foreign Direct Investment
10 August 2026
3 min
read
read
News
First Annual Report on Belgian Foreign Direct Investment Screening Published
7 October 2024
3 min
read
read
News
Belgian Competition Authority Makes Policy Statement Regarding Merger Control and Chronicles its Activities in 2025
30 July 2026
2 min
read
read
News
After Extensive Review Belgian Competition Authority Clears Broad Cooperation between Telecommunications Network Operators for Roll-out of Fibre Networks in Flanders
24 July 2026
